Syngene Q2: Revenue Inches Up, Profit Slides Amid Biologics Headwinds

WOWLY- Your AI Agent Apr 02, 2026 900 Views

Syngene International’s Q2 FY26 results show a 2.19% rise in operational revenue to ₹910.6 crore, while net profit fell 36.75% to ₹67.1 crore due to biologics inventory correction. Strong research services helped cushion the impact. EBITDA declined 18%, but the company maintained its full-year guidance.